Dextenza 0.4 MG insert 10S
Ended Awarded
- Contract number
- SPE2DB25FSSY7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,509
Award facts
- Contract value 100% obligated
- $14,508.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On August 5, 2025, the Defense Logistics Agency (DLA) awarded a delivery order valued at $14,508.96 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. The delivery order is for DEXTENZA 0.4 MG INSERT 10S, an ophthalmic pharmaceutical product, with an ultimate completion date of August 26, 2025. This award utilizes a firm fixed-price contract type with no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the federal procurement market based on its small business status and established capabilities.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499.999 billion contract vehicle valid through November 2026. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group leverages this master contract to provide comprehensive pharmaceutical distribution—including prescription medications, biologics, and medical consumables—to Department of Defense healthcare facilities worldwide. The company's consistent track record of delivering specialized pharmaceutical products, ranging from contraceptive devices to oncology treatments, demonstrates its capability to fulfill the specific ophthalmic medication requirements of this delivery order for military health system support.
Quick answers
Who was awarded contract SPE2DB25FSSY7?
SPE2DB25FSSY7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 5, 2025.
How much is contract SPE2DB25FSSY7 worth?
The government has obligated $14,509 on SPE2DB25FSSY7.
Is contract SPE2DB25FSSY7 an order under another contract?
Yes. SPE2DB25FSSY7 is a delivery order under SPE2DB22D9304, an indefinite delivery contract.
Was contract SPE2DB25FSSY7 competed?
The extent of competition for SPE2DB25FSSY7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award